Yisa Bray: In the past, many pharmaceutical firms (pharmacies) prioritized other business pressures over operations strategy. This has started to alter. Pharmacists must carefully reevaluate their long-term decisions in sourcing, production, and supply chain in light of factors like the COVID-19 pandemic, inflation, geopolitics, new therapeutic modalities, and new ways of working.